Peripheral blood markers predict prognosis and irAEs of stage IV driver gene-negative lung adenocarcinoma treated with ICIs
ObjectiveThis study aims to evaluate the prognostic significance of peripheral blood biomarkers in relation to outcomes and immune-related adverse events (irAEs) among patients with stage IV driver gene-negative lung adenocarcinoma receiving treatment with immune checkpoint inhibitors (ICIs).Methods...
Saved in:
| Main Authors: | Yu Li, Lei Cao, Lei Liu, Yawen Ding, Feng Cao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1538392/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiviral therapy can effectively suppress irAEs in HBV positive hepatocellular carcinoma treated with ICIs: validation based on multi machine learning
by: Shuxian Pan, et al.
Published: (2025-01-01) -
Effects of COVID-19 vaccination on irAEs and prognosis in lung cancer patients receive PD-(L)1 inhibitors
by: Ping Luo, et al.
Published: (2025-12-01) -
Prognostic significance of systemic inflammatory markers in oropharyngeal squamous cell carcinoma
by: Jan Horackiewicz, et al.
Published: (2025-09-01) -
The baseline circulating immunophenotype characteristics associate with PD(L)-1 targeted treatment response, irae onset, and prognosis
by: Xiaomin Fu, et al.
Published: (2025-05-01) -
Editorial for “a predictive model for irAEs in ESCC patients treated with PD-1 inhibitors based on blood indicators”
by: Yaser Soleimani, et al.
Published: (2025-12-01)